Patent · US Active

Aryl-n-aryl derivatives for treating a RNA virus infection

US12247018B2 · kind B2 · utility

0Cited by

2References

17Claims

0Family size

Assignees

ABIVAX · FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR
Universite De Montpellier · FR
INSTITUT CURIE · FR

Inventors

Didier Scherrer · Castelnau-le-Lez, FR
Jamal Tazi · Clapiers, FR
Florence Mahuteau-Betzer · Saint-Remy, FR
Romain Najman · L'Haÿ-les-Roses, FR
Julien SANTO · Montpellier, FR
Cécile Apolit · Grabels, FR

Key dates

Filing date	Jul 9, 2019
Grant date	Mar 11, 2025
Priority date	—
Expiry date	Dec 28, 2041

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

A compound of formula (Ic) a group, a group, a morpholinyl group, optionally substituted by a (C1-C4)alkyl group, a piperazinyl group, a piperidinyl group, or a —CR1R2R3 group, or any of its pharmaceutically acceptable salt.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.